Previous Article | Next Article ![]()
J Virol, February 1998, p. 1020-1027, Vol. 72, No. 2
Departments of Microbiology-Immunology and
Pathology and Institute for Neuroscience, Northwestern University
Medical School, Chicago, Illinois 60611
Received 2 July 1997/Accepted 30 October 1997
Theiler's murine encephalomyelitis virus (TMEV) induces
immune-mediated demyelination after intracerebral inoculation of the virus into susceptible mouse strains. We isolated from a TMEV BeAn 8386 viral stock, a low-pathogenic variant which requires greater than a
10,000-fold increase in viral inoculation for the manifestation of
detectable clinical signs. Intracerebral inoculation of this variant
virus induced a strong, long-lasting, protective immunity from the
demyelinating disease caused by pathogenic TMEV. The levels of
antibodies to the whole virus as well as to the major linear epitopes
were similar in mice infected with either the variant or wild-type
virus. However, persistence of the variant virus in the central nervous
system (CNS) of mice was significantly lower than that of the
pathogenic virus. In addition, the T-cell response to the predominant
VP1 (VP1233-250) epitope in mice infected with the variant
virus was significantly weaker than that in mice infected with the
parent virus, while similar T-cell responses were induced against
another predominant epitope (VP274-86). Further analyses
indicated that a change of lysine to arginine at position 244 of VP1,
which is the only amino acid difference in the P1 region, is
responsible for such differential T-cell recognition. Thus, the
difference in the T-cell reactivity to this VP1 region as well as the
low level of viral persistence in the CNS may account for the low
pathogenicity of this spontaneous variant virus.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
A Spontaneous Low-Pathogenic Variant of Theiler's
Virus Contains an Amino Acid Substitution within the Predominant
VP1233-250 T-Cell Epitope

*
Corresponding author. Mailing address: Department of
Microbiology-Immunology, Northwestern University Medical School, 303 E. Chicago Ave., Chicago, IL 60611. Phone: (312) 503-8693. Fax: (312)
503-1339. E-mail: bskim{at}nwu.edu.
Present address: Dana-Farber Cancer Research Institute, Harvard
Medical School, Boston, MA 02115.
Present address: Science Applications International Corp.,
Frederick, MD 21702.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»